Immunosuppression by pyrimidine nucleoside analogs.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000963:Antimetabolites / Q000494:pharmacology*; D001379:Azathioprine / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002701:Chloramphenicol / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology*; D003597:Cytosine Nucleotides / Q000494:pharmacology*; D004912:Erythrocytes; D005467:Floxuridine / Q000494:pharmacology*; D006386:Hemagglutination Tests; D007065:Idoxuridine / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008623:Mercaptoethanol / Q000494:pharmacology*; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D009705:Nucleosides / Q000494:pharmacology*; D012756:Sheep
D000963:Antimetabolites; D003597:Cytosine Nucleotides; D009705:Nucleosides; D005467:Floxuridine; D003561:Cytarabine; D008623:Mercaptoethanol; D002701:Chloramphenicol; D015122:Mercaptopurine; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D001379:Azathioprine; D008727:Methotrexate